However, in this model, % P2 of tumor CD8+ T cells was the most strongly weighted feature (0.0733 ± 0.0641) and the 4- and 5-year AUCs were higher than in Model 1 [4-year AUC = 82.9% (95% CI = 70.85-94.94), 5-year AUC = 80.6% (95% CI = 68.44-92.71), Figure 5C]. This evidence concerns the gene CD8A and neoplasm.